Patient Benefits of Radical Prostatectomy in Certified Prostate Cancer Centers: Comparative Results from the Multicenter IMPROVE Study.

Certification German cancer society Patient‐reported outcome Prostate cancer Radical prostatectomy

Journal

Urologia internationalis
ISSN: 1423-0399
Titre abrégé: Urol Int
Pays: Switzerland
ID NLM: 0417373

Informations de publication

Date de publication:
06 Nov 2023
Historique:
received: 28 07 2023
accepted: 02 09 2023
medline: 7 11 2023
pubmed: 7 11 2023
entrez: 6 11 2023
Statut: aheadofprint

Résumé

We investigated differences in treatment outcomes following radical prostatectomy (RP) between certified centers (CCs) and noncertified centers (nCCs) within the IMPROVE study group. A validated survey assessing various factors, including stress urinary incontinence (SUI) and decision regret (DR), was administered to 950 patients who underwent RP across 19 hospitals (12 CCs and 7 nCCs) at a median follow-up of 15 months after RP (interquartile range: 11-20). The response rate was 74%, with 703 patients participating, including 480 (68%) from CCs. Multivariate binary regression models were used to analyze differences between CCs and nCCs regarding the following binary endpoints: nerve-sparing (NS), positive surgical margins (PSM), SUI (defined as >1 safety pad), complications based on the Clavien-Dindo classification (grade ≥1, grade ≥3) and DR (>15 points indicating critical DR). Considering the multivariate analysis, the rate of NS surgery was lower in CCs than in nCCs (OR = 0.52; p = 0.004). No significant differences were observed in the PSM rate (OR = 1.67; p = 0.051), SUI (OR = 1.03; p = 0.919), and DR (OR = 1.00; p = 0.990). SUI (OR 0.39; p < 0.001) and DR (OR 0.62; p = 0.026) were reported significantly less frequently by patients treated with robotic-assisted RP, which was significantly more often performed in CCs than in nCCs (68.3% vs. 18%; p < 0.001). The total complication rate was 45% lower in CCs (OR = 0.55; p = 0.004), although the number of complications requiring intervention (Clavien-Dindo classification ≥3) did not differ significantly between CCs and nCCs (OR = 2.52; p = 0.051). Within the IMPROVE study group, similarly favorable outcomes after RP were found in both CCs and nCCs, which, however, cannot be transferred to the general treatment landscape of PCA in Germany. Of note, robotic-assisted RP was more often performed in CCs and associated with less SUI and DR, while open prostatectomy was the treatment of choice in low-volume nCCs. Future prospective and region wide studies should also investigate the surgeon caseload and experience as well as a spillover effect of the certification process on nCCs.

Identifiants

pubmed: 37931610
pii: 000534486
doi: 10.1159/000534486
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1-10

Informations de copyright

© 2023 S. Karger AG, Basel.

Auteurs

Danijel Sikic (D)

Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Christian Fiebig (C)

Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Bernd Wullich (B)

Department of Urology and Pediatric Urology, University Hospital Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Comprehensive Cancer Center Erlangen-EMN (CCC ER-EMN), Erlangen, Germany.

Ingmar Wolff (I)

Department of Urology, University Medicine Greifswald, Greifswald, Germany.

Bernd Hoschke (B)

Department of Urology and Pediatric Urology, Carl-Thiem-Klinikum Cottbus, Cottbus, Germany.

Andreas Manseck (A)

Department of Urology, Klinikum Ingolstadt, Ingolstadt, Germany.

Rolf Gillitzer (R)

Department of Urology, Klinikum Darmstadt, Darmstadt, Germany.

Maximilian Burger (M)

Department of Urology, St. Josef-Hospital Regensburg, Medical University Regensburg, Regensburg, Germany.

Julie Steinestel (J)

Department of Urology, University Hospital Augsburg, Augsburg, Germany.

Nina Harke (N)

Department of Urology and Urologic Oncology, Hannover Medical School, Hannover, Germany.

Niklas Löbig (N)

Department of Urology and Pediatric Urology, Universitätsklinikum Ulm, Ulm, Germany.

Florian A Distler (FA)

Department of Urology, Paracelsus Medical University, Nuremberg, Germany.

Matthias May (M)

Department of Urology, St. Elisabeth Hospital Straubing, Straubing, Germany.

Julia Peter (J)

Department of Urology, St. Elisabeth Hospital Straubing, Straubing, Germany.

Christian Gilfrich (C)

Department of Urology, St. Elisabeth Hospital Straubing, Straubing, Germany.

Classifications MeSH